Navigation Links
Avanafil Data Presented at the European Society of Sexual Medicine Meeting
Date:12/5/2011

MOUNTAIN VIEW, Calif., Dec. 5, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that multiple abstracts were presented over the weekend at the 2011 European Society of Sexual Medicine (ESSM) Meeting in Milan, Italy.  The ESSM is the largest gathering of medical professionals specializing in sexual dysfunction and treatment in Europe.

The specific abstracts that were presented on December 3rd, 2011 include:

A moderated poster presentation by Laurence H. Belkoff, DO, FACOS, Chairman of the Department of Specialty Surgeries and the Division of Urology at the Philadelphia College of Osteopathic Medicine, entitled:

An Open-label, Long-term Evaluation of the Safety and Tolerability of Avanafil in Males with Erectile Dysfunction

Dr. Belkoff reported that in the study (TA-314) avanafil met all endpoints by demonstrating sustained improvement from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP 2 and SEP 3) and improvements in the International Index of Erectile Function (IIEF).  The study also suggested a favorable side effect profile and successful intercourse (as measured by SEP 3) in as little as 15 minutes in some patients, without any restrictions on food or alcohol intake.  More than 88% of subjects study-wide responded to treatment with avanafil 100mg or 200mg.

A moderated poster presentation by Run Wang, MD, Associate Professor of Surgery in the Division of Urology and holder of the Cecil M. Crigler, MD Chair in Urology at the University of Texas Health Science Center in Houston, entitled:

Avanafil, a Highly Selective Phosphodiesterase Type 5 Inhibitor for the Treatment of Erectile Dysfunction: Selectivity for Eleven PDE Isozymes, in Comparison With Sildenafil, Tadalafil and Vardenafil

Dr. Wang shared his analysis of avanafil selectivity for the ele
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Avanafil Data to be Presented at the Sexual Medicine Society of North America Meeting
2. Positive Results From Avanafil Phase 3 Study in Diabetics Presented at the 47th EASD Annual Meeting
3. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
4. Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
5. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
6. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
7. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
8. New Data Demonstrating the Impact of Opioid-Related Adverse Events on Total Hospital Cost Presented at American Society of Health-System Pharmacists Meeting
9. New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society
10. Biodesix Announces New VeriStrat® Data to be Presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
11. XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Calif. , Sept. 3, 2015  Four ... in a white paper released by Leaf ... Agency for Healthcare Research & Quality (AHRQ), ... estimated $9.1-$11.6 billion annually . In addition to ... in litigation, government penalties, and negatively impact hospital ...
(Date:9/3/2015)... 3, 2015 Research and Markets ( ... "Investigation Report on China Tamsulosin Market, 2010-2019" ... Compared with other a1- adrenergic receptor blockers, tamsulosin ... lower risk of urinary tract infections and therefore ... debut in 1993 in Japan ...
(Date:9/3/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/f5wtsh/investigation ... "Investigation Report on China Phosphocreatine Market, 2010-2019" ... epidemic trend shows that cardiovascular disease has become ... whose incidence and death rate has exceeded that ... According to the World Health Organization (WHO), about ...
Breaking Medicine Technology:Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3China Tamsulosin Market Investigation Report 2015 2China Phosphocreatine Market Report 2015-2019 2
... 2011 Northwest Biotherapeutics (OTC.BB: NWBO) today announced that ... exceeding its projections for the doubling of such sites ... new patients into the Company,s ongoing 240-patient randomized, double ... for Glioblastoma multiforme (GBM), the most lethal form of ...
... A study titled "Abiraterone and Increased Survival ... 26 issue of NEJM, found that ... received prior chemotherapy containing docetaxel showed a significant ... ™ (abiraterone acetate) plus prednisone compared to ...
Cached Medicine Technology:Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial 2Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 2Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 3Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 4Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 5Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate) 6
(Date:9/3/2015)... ... September 03, 2015 , ... B. E. Smith, the only ... lead a national chief executive officer recruitment for Melissa Memorial Hospital ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:9/3/2015)... ... ... Global Vision , the world leader in the development of innovative ... inspection solutions, ScanProof and ArtProof at Packaging Innovations 2015. , Join ... , Be the first to get a sneak peek of Intelligent Proofreading. Global Vision’s ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters ... pleased to announce the additional of Carol Wysham, MD, to their esteemed Board ... Diana Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda ...
(Date:9/3/2015)... ... ... ProScrub is a set of automated tools that allow Final Cut Pro ... without the use of keyframes. Utilize ProScrub's powerful sliders to determine the number ... to energetic video productions. ProScrub is a Final Cut Pro X ...
(Date:9/3/2015)... ... 03, 2015 , ... AvePoint, the established leader in enabling enterprise ... 4 – AvePoint’s solution for facilitating two-way collaboration and external sharing without ever ... This is the fifth consecutive year an AvePoint product has made the list. ...
Breaking Medicine News(10 mins):Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:FCPX Effects Developer Releases ProScrub for Final Cut Pro X 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4
... the disheartening reasons behind her recent weight loss. ... emaciated in all her recent public appearances, admitted that she ... revealed that her worrying weight loss is a result of ... lean and this year I lost my mom and I've ...
... Moylan of St.Lucie County was driven to a West ... for urgent treatment of a splitting headache. ... behind his right ear. And his wife April Moylan ... wife offered conflicting explanations throughout the day, the latter ...
... of the first studies of social sources of alcohol ... were willing to purchase alcohol for underage youth .Many ... Most of them obtain alcohol from social sources of ... opposed to commercial sources. , ,Many types ...
... to worry about the doctor's needle, for a new study ... just as well as injections. ,The first of ... showed that kids children given oral treatment recovered as quickly, ... were able to go home sooner than those given intravenous ...
... of CD38 gene prevented mice on high-fat diets from gaining weight. ... researchers led by Eduardo Chini at Mayo Clinic. ,As ... one with the gene CD38 and the other without. Each group ... fat. In a second test, each group was fed a standard ...
... Tuesday with the death of a ninth child who contracted ... centre said. ,The death came as a ... officials accused in the case for negligence, corruption and fraud. ... in prison. ,The accused have all denied the ...
Cached Medicine News:Health News:Headache Complaint Leads to Removal of Bullet 2Health News:Underage Youth Get Alcohol from Social Sources 2Health News:Underage Youth Get Alcohol from Social Sources 3Health News:Oral Treatment as Effective as Injections in Treating Kids With Pneumonia 2Health News:Boffins Identify Gene That Helps Regulates Body Weight 2
... The Stryker Threaded ... surgeon yet another choice ... tunnel. Dilators provide compaction ... The compaction of bone ...
... Stryker Conquest Suture Retrievers ... that pierce through soft ... through the tissue to ... Conquest Retrievers are front ...
... The Arthroscopy Scissor is ideal for excising ... tissue debris in the joint. The serrated edge ... as well as hold tissue within the jaws ... left and right jaw curvatures, are the perfect ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
Medicine Products: